SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 240.58 |
| Enterprise Value ($M) | 1,555.67 |
| Book Value ($M) | 443.47 |
| Book Value / Share | 3.47 |
| Price / Book | 0.54 |
| NCAV ($M) | 398.90 |
| NCAV / Share | 3.12 |
| Price / NCAV | 0.60 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.10 |
| Return on Assets (ROA) | -0.10 |
| Return on Equity (ROE) | -0.11 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 17.09 |
| Current Ratio | 17.09 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 430.23 |
| Assets | 474.79 |
| Liabilities | 31.32 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Morgan Stanley | 11.10 | 29.28 | |
| 13G | BlackRock, Inc. | 5.10 | 0.00 | |
| 13G/A | Suvretta Capital Management, Llc | 10.47 | 179.32 | |
| 13D/A | Control Empresarial de Capitales S.A. de C.V. | 25.30 | 13.37 | |
| 13D/A | Tolerantia, LLC | 38.70 | 25.52 | |
| 13D/A | Palihapitiya Chamath | 4.50 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 127,173 | 379,961 | 33.47 | |
| 126,118 | 483,784 | 26.07 | |
| 90,408 | 315,445 | 28.66 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| PMCB – PharmaCyte Biotech, Inc. | PMN – ProMIS Neurosciences, Inc. |
| PRFX – PainReform Ltd. | PRPH – ProPhase Labs, Inc. |
| PRQR – ProQR Therapeutics N.V. |
Financial data and stock pages provided by
Fintel.io